Cardiovascular Research

Functional and histological assessment of an experimental model of Takotsubo's cardiomyopathy.

Authors: Jaspreet Sachdeva|||Wangde Dai|||Robert A Kloner

Affiliations: + Expand

Abstract

Our objectives were to characterize functional and structural features of an experimental model of Takotsubo cardiomyopathy, and its response to beta-blockers.

---

Chemical List

Adrenergic beta-Antagonists|||Propranolol|||Metoprolol

---

Reference List

Yatsinyuk BB. Hemodynamic disturbances and activation of lipid peroxidation in the pathogenesis of acute myocardial injury induced by propranolol in toxic doses. Bull Exp Biol Med. 2011; 151:308-310.|||Owczarek J, Jasińska M, Orszulak‐Michalak D. Interaction between different doses of simvastatin after two‐week administration and metoprolol injection on the heart rate in normocholesterolemic rats. Acta Pol Pharm. 2008; 65:141-145.|||Kloner RA, Ganote CE, Whalen DA, Jr, Jennings RB. Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of reflow. Am J Pathol. 1974; 74:399-422.|||Ellison GM, Torella D, Karakikes I, Purushothaman S, Curcio A, Gasparri C, Indolfi C, Cable NT, Goldspink DF, Nadal‐Ginard B. Acute beta‐adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells. J Biol Chem. 2007; 282:11397-11409.|||Akashi YJ, Goldstein DS, Barbaro G, Ueyama T. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation. 2008; 118:2754-2762.|||Wittstein IS. Stress cardiomyopathy: a syndrome of catecholamine‐mediated myocardial stunning? Cell Mol Neurobiol. 2012; 32:847-857.|||Shao Y, Redfors B, Scharin Täng M, Möllmann H, Troidl C, Szardien S, Hamm C, Nef H, Borén J, Omerovic E. Novel rat model reveals important roles of β‐adrenoreceptors in stress‐induced cardiomyopathy. Int J Cardiol. 2013; 168:1943-1950.|||Paur H, Wright PT, Sikkel MB, Tranter MH, Mansfield C, O'Gara P, Stuckey DJ, Nikolaev VO, Diakonov I, Pannell L, Gong H, Sun H, Peters NS, Petrou M, Zheng Z, Gorelik J, Lyon AR, Harding SE. High levels of circulating epinephrine trigger apical cardiodepression in a β2‐adrenergic receptor/Gi‐dependent manner: a new model of Takotsubo cardiomyopathy. Circulation. 2012; 126:697-706.|||Elsokkari I, Cala A, Khan S, Hill A. Takotsubo cardiomyopathy: not always innocent or predictable. A unique post mortem insight. Int J Cardiol. 2013; 167:e46-e48.|||Iacucci I, Carbone I, Cannavale G, Conti B, Iampieri I, Rosati R, Sardella G, Frustaci A, Fedele F, Catalano C, Francone M. Myocardial oedema as the sole marker of acute injury in Takotsubo cardiomyopathy: a cardiovascular magnetic resonance (CMR) study. Radiol Med. 2013; 118:1309-1323.|||Shao Y, Redfors B, Ståhlman M, Täng MS, Miljanovic A, Möllmann H, Troidl C, Szardien S, Hamm C, Nef H, Borén J, Omerovic E. A mouse model reveals an important role for catecholamine‐induced lipotoxicity in the pathogenesis of stress‐induced cardiomyopathy. Eur J Heart Fail. 2013; 15:9-22.|||Ibrahim T, Nekolla SG, Langwieser N, Rischpler C, Groha P, Laugwitz KL, Schwaiger M. Simultaneous positron emission tomography/magnetic resonance imaging identifies sustained regional abnormalities in cardiac metabolism and function in stress‐induced transient midventricular ballooning syndrome: a variant of Takotsubo cardiomyopathy. Circulation. 2012; 126:e324-e326.|||Mori H, Ishikawa S, Kojima S, Hayashi J, Watanabe Y, Hoffman JI, Okino H. Increased responsiveness of left ventricular apical myocardium to adrenergic stimuli. Cardiovasc Res. 1993; 27:192-198.|||Izumi Y, Okatani H, Shiota M, Nakao T, Ise R, Kito G, Miura K, Iwao H. Effects of metoprolol on epinephrine‐induced takotsubo‐like left ventricular dysfunction in non‐human primates. Hypertens Res. 2009; 32:339-346.|||Ishikura F, Takano Y, Ueyama T. Acute effects of beta‐blocker with intrinsic sympathomimetic activity on stress‐induced cardiac dysfunction in rats. J Cardiol. 2012; 60:470-474.|||Palla AR, Dande AS, Petrini J, Wasserman HS, Warshofsky MK. Pretreatment with low‐dose β‐adrenergic antagonist therapy does not affect severity of Takotsubo cardiomyopathy. Clin Cardiol. 2012; 35:478-481.|||Kyuma M, Tsuchihashi K, Shinshi Y, Hase M, Nakata T, Ooiwa H, Abiru M, Hikita N, Adachi T, Shoji T, Fujise Y, Shimamoto K. Effect of intravenous propranolol on left ventricular apical ballooning without coronary artery stenosis (ampulla cardiomyopathy): three cases. Circ J. 2002; 66:1181-1184.|||Yoshioka T, Hashimoto A, Tsuchihashi K, Nagao K, Kyuma M, Ooiwa H, Nozawa A, Shimoshige S, Eguchi M, Wakabayashi T, Yuda S, Hase M, Nakata T, Shimamoto K. Clinical implications of midventricular obstruction and intravenous propranolol use in transient left ventricular apical ballooning (Tako‐tsubo cardiomyopathy). Am Heart J. 2008; 155:526.e1-526.e7.